+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Metagenomic Sequencing Market Research Report by Product & Service, Workflow, Technology, Application, State - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - United States Forecast 2023-2030

  • PDF Icon

    Report

  • 126 Pages
  • January 2023
  • Region: United States
  • 360iResearch™
  • ID: 5722317
The United States Metagenomic Sequencing Market is projected to grow with a significant CAGR in the forecast period. Economic development and substantial infrastructure development have constituted regional revenue generation. Further, the patterns associated with domestic production, import and export, and consumption have helped market participants to analyze and capitalize on potential opportunities. Besides, the qualitative and quantitative parameters provided in the report with detailed analysis highlights the driving and restraining factors of the United States Metagenomic Sequencing Market.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the United States Metagenomic Sequencing Market.

Cumulative Impact of Russia-Ukraine Conflict:

The publisher continuously monitors and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the United States Metagenomic Sequencing Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The United States Metagenomic Sequencing Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the United States Metagenomic Sequencing Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. The market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan. This research report categorizes the United States Metagenomic Sequencing Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product & Service, the market is studied across Analysis & Data Interpretation Solutions, Instruments, Reagents & Consumables, and Services.
  • Based on Workflow, the market is studied across Data Processing & Analysis, Sample Processing & Library Preparation, and Sequencing.
  • Based on Technology, the market is studied across 16S rRNA Sequencing, Metatranscriptomics, Shotgun Metagenomic Sequencing, and Whole-genome Sequencing & De Novo Assembly.
  • Based on Application, the market is studied across Clinical Diagnostics, Drug Discovery, Ecological & Environmental Applications, Industrial applications, Soil Microbiome Applications, and Veterinary Applications.
  • Based on State, the market is studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the United States Metagenomic Sequencing Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The United States Metagenomic Sequencing Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The United States Metagenomic Sequencing Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The United States Metagenomic Sequencing Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Metagenomic Sequencing Market, including Azenta US, Inc., BGI Genomics Co., Ltd., CosmosID, DNASTAR, Inc., Eurofins Genomics Germany GmbH, Freenome Holdings, Inc., IntegraGen S.A., Macrogen Europe BV, Microsynth AG, Novogene Co., Ltd., Oxford Nanopore Technologies PLC, Pacific Biosciences of California, Inc., PerkinElmer Inc., Psomagen, Inc., and QIAGEN GmbH.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the United States Metagenomic Sequencing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Metagenomic Sequencing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Metagenomic Sequencing Market?
4. What is the competitive strategic window for opportunities in the United States Metagenomic Sequencing Market?
5. What are the technology trends and regulatory frameworks in the United States Metagenomic Sequencing Market?
6. What is the market share of the leading vendors in the United States Metagenomic Sequencing Market?
7. What modes and strategic moves are considered suitable for entering the United States Metagenomic Sequencing Market?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing requirement for the evaluation of bacterial diversity and detection of abundant microbes
5.1.1.2. Rising genetic disorders coupled with government and private sector support for sequencing projects
5.1.2. Restraints
5.1.2.1. Insufficient data storage for the sequencing data
5.1.3. Opportunities
5.1.3.1. Increasing applications of metagenomic technologies in many fields
5.1.3.2. Ongoing development of metagenomic sequencing in the U.S.
5.1.4. Challenges
5.1.4.1. Unavailability of skilled and experienced workforce
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization

6. Metagenomic Sequencing Market, by Product & Service
6.1. Introduction
6.2. Analysis & Data Interpretation Solutions
6.3. Instruments
6.4. Reagents & Consumables
6.5. Services

7. Metagenomic Sequencing Market, by Workflow
7.1. Introduction
7.2. Data Processing & Analysis
7.3. Sample Processing & Library Preparation
7.4. Sequencing

8. Metagenomic Sequencing Market, by Technology
8.1. Introduction
8.2. 16S rRNA Sequencing
8.3. Metatranscriptomics
8.4. Shotgun Metagenomic Sequencing
8.5. Whole-genome Sequencing & De Novo Assembly

9. Metagenomic Sequencing Market, by Application
9.1. Introduction
9.2. Clinical Diagnostics
9.3. Drug Discovery
9.4. Ecological & Environmental Applications
9.5. Industrial applications
9.6. Soil Microbiome Applications
9.7. Veterinary Applications

10. California Metagenomic Sequencing Market
10.1. Introduction

11. Florida Metagenomic Sequencing Market
11.1. Introduction

12. Illinois Metagenomic Sequencing Market
12.1. Introduction

13. New York Metagenomic Sequencing Market
13.1. Introduction

14. Ohio Metagenomic Sequencing Market
14.1. Introduction

15. Pennsylvania Metagenomic Sequencing Market
15.1. Introduction

16. Texas Metagenomic Sequencing Market
16.1. Introduction

17. Competitive Landscape
17.1. FPNV Positioning Matrix
17.1.1. Quadrants
17.1.2. Business Strategy
17.1.3. Product Satisfaction
17.2. Market Ranking Analysis, By Key Player
17.3. Market Share Analysis, By Key Player
17.4. Product Portfolio Analysis, By Key Player
17.5. Competitive Scenario
17.5.1. Merger & Acquisition
17.5.2. Agreement, Collaboration, & Partnership
17.5.3. New Product Launch & Enhancement
17.5.4. Investment & Funding
17.5.5. Award, Recognition, & Expansion

18. Company Usability Profiles
18.1. Azenta US, Inc.
18.2. BGI Genomics Co., Ltd.
18.3. CosmosID
18.4. DNASTAR, Inc.
18.5. Eurofins Genomics Germany GmbH
18.6. Freenome Holdings, Inc.
18.7. IntegraGen S.A.
18.8. Macrogen Europe BV
18.9. Microsynth AG
18.10. Novogene Co., Ltd.
18.11. Oxford Nanopore Technologies PLC
18.12. Pacific Biosciences of California, Inc.
18.13. PerkinElmer Inc.
18.14. Psomagen, Inc.
18.15. QIAGEN GmbH

19. Appendix
19.1. Discussion Guide
19.2. License & Pricing

List of Figures
FIGURE 1. UNITED STATES METAGENOMIC SEQUENCING MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, 2022 VS 2030
FIGURE 3. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 5. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. UNITED STATES METAGENOMIC SEQUENCING MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 7. UNITED STATES METAGENOMIC SEQUENCING MARKET DYNAMICS
FIGURE 8. UNITED STATES METAGENOMIC SEQUENCING MARKET PORTER’S FIVE FORCES ANALYSIS
FIGURE 9. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2022 VS 2030 (%)
FIGURE 10. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. UNITED STATES METAGENOMIC SEQUENCING MARKET COMPETITIVE STRATEGIC WINDOW, BY PRODUCT & SERVICE, 2030
FIGURE 12. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY ANALYSIS & DATA INTERPRETATION SOLUTIONS, 2018-2030 (USD MILLION)
FIGURE 13. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
FIGURE 14. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
FIGURE 15. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
FIGURE 16. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2022 VS 2030 (%)
FIGURE 17. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES METAGENOMIC SEQUENCING MARKET COMPETITIVE STRATEGIC WINDOW, BY WORKFLOW, 2030
FIGURE 19. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY DATA PROCESSING & ANALYSIS, 2018-2030 (USD MILLION)
FIGURE 20. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY SAMPLE PROCESSING & LIBRARY PREPARATION, 2018-2030 (USD MILLION)
FIGURE 21. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
FIGURE 22. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
FIGURE 23. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 24. UNITED STATES METAGENOMIC SEQUENCING MARKET COMPETITIVE STRATEGIC WINDOW, BY TECHNOLOGY, 2030
FIGURE 25. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY 16S RRNA SEQUENCING, 2018-2030 (USD MILLION)
FIGURE 26. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY METATRANSCRIPTOMICS, 2018-2030 (USD MILLION)
FIGURE 27. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, 2018-2030 (USD MILLION)
FIGURE 28. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY WHOLE-GENOME SEQUENCING & DE NOVO ASSEMBLY, 2018-2030 (USD MILLION)
FIGURE 29. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 30. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 31. UNITED STATES METAGENOMIC SEQUENCING MARKET COMPETITIVE STRATEGIC WINDOW, BY APPLICATION, 2030
FIGURE 32. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
FIGURE 33. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
FIGURE 34. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY ECOLOGICAL & ENVIRONMENTAL APPLICATIONS, 2018-2030 (USD MILLION)
FIGURE 35. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY INDUSTRIAL APPLICATIONS, 2018-2030 (USD MILLION)
FIGURE 36. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY SOIL MICROBIOME APPLICATIONS, 2018-2030 (USD MILLION)
FIGURE 37. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY VETERINARY APPLICATIONS, 2018-2030 (USD MILLION)
FIGURE 38. CALIFORNIA METAGENOMIC SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 39. FLORIDA METAGENOMIC SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 40. ILLINOIS METAGENOMIC SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 41. NEW YORK METAGENOMIC SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 42. OHIO METAGENOMIC SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 43. PENNSYLVANIA METAGENOMIC SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 44. TEXAS METAGENOMIC SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 45. UNITED STATES METAGENOMIC SEQUENCING MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 46. UNITED STATES METAGENOMIC SEQUENCING MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 47. UNITED STATES METAGENOMIC SEQUENCING MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022


List of Tables
TABLE 1. UNITED STATES METAGENOMIC SEQUENCING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 5. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 6. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY ANALYSIS & DATA INTERPRETATION SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 7. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY ANALYSIS & DATA INTERPRETATION SOLUTIONS, BY STATE, 2018-2030 (USD MILLION)
TABLE 8. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 9. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY INSTRUMENTS, BY STATE, 2018-2030 (USD MILLION)
TABLE 10. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 11. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY REAGENTS & CONSUMABLES, BY STATE, 2018-2030 (USD MILLION)
TABLE 12. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 13. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY SERVICES, BY STATE, 2018-2030 (USD MILLION)
TABLE 14. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 15. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY DATA PROCESSING & ANALYSIS, 2018-2030 (USD MILLION)
TABLE 16. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY DATA PROCESSING & ANALYSIS, BY STATE, 2018-2030 (USD MILLION)
TABLE 17. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY SAMPLE PROCESSING & LIBRARY PREPARATION, 2018-2030 (USD MILLION)
TABLE 18. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY SAMPLE PROCESSING & LIBRARY PREPARATION, BY STATE, 2018-2030 (USD MILLION)
TABLE 19. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
TABLE 20. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY SEQUENCING, BY STATE, 2018-2030 (USD MILLION)
TABLE 21. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 22. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY 16S RRNA SEQUENCING, 2018-2030 (USD MILLION)
TABLE 23. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY 16S RRNA SEQUENCING, BY STATE, 2018-2030 (USD MILLION)
TABLE 24. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY METATRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 25. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY METATRANSCRIPTOMICS, BY STATE, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, 2018-2030 (USD MILLION)
TABLE 27. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, BY STATE, 2018-2030 (USD MILLION)
TABLE 28. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY WHOLE-GENOME SEQUENCING & DE NOVO ASSEMBLY, 2018-2030 (USD MILLION)
TABLE 29. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY WHOLE-GENOME SEQUENCING & DE NOVO ASSEMBLY, BY STATE, 2018-2030 (USD MILLION)
TABLE 30. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY STATE, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY DRUG DISCOVERY, BY STATE, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY ECOLOGICAL & ENVIRONMENTAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY ECOLOGICAL & ENVIRONMENTAL APPLICATIONS, BY STATE, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY INDUSTRIAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY INDUSTRIAL APPLICATIONS, BY STATE, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY SOIL MICROBIOME APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY SOIL MICROBIOME APPLICATIONS, BY STATE, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY VETERINARY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY VETERINARY APPLICATIONS, BY STATE, 2018-2030 (USD MILLION)
TABLE 43. CALIFORNIA METAGENOMIC SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 44. CALIFORNIA METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 45. CALIFORNIA METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 46. CALIFORNIA METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 47. CALIFORNIA METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. FLORIDA METAGENOMIC SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 49. FLORIDA METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 50. FLORIDA METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 51. FLORIDA METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 52. FLORIDA METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. ILLINOIS METAGENOMIC SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 54. ILLINOIS METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 55. ILLINOIS METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 56. ILLINOIS METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 57. ILLINOIS METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. NEW YORK METAGENOMIC SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 59. NEW YORK METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 60. NEW YORK METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 61. NEW YORK METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 62. NEW YORK METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. OHIO METAGENOMIC SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 64. OHIO METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 65. OHIO METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 66. OHIO METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 67. OHIO METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. PENNSYLVANIA METAGENOMIC SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 69. PENNSYLVANIA METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 70. PENNSYLVANIA METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 71. PENNSYLVANIA METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 72. PENNSYLVANIA METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. TEXAS METAGENOMIC SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 74. TEXAS METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 75. TEXAS METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 76. TEXAS METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 77. TEXAS METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES METAGENOMIC SEQUENCING MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 79. UNITED STATES METAGENOMIC SEQUENCING MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 80. UNITED STATES METAGENOMIC SEQUENCING MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 81. UNITED STATES METAGENOMIC SEQUENCING MARKET RANKING, BY KEY PLAYER, 2022
TABLE 82. UNITED STATES METAGENOMIC SEQUENCING MARKET SHARE, BY KEY PLAYER, 2022
TABLE 83. UNITED STATES METAGENOMIC SEQUENCING MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 84. UNITED STATES METAGENOMIC SEQUENCING MARKET MERGER & ACQUISITION
TABLE 85. UNITED STATES METAGENOMIC SEQUENCING MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 86. UNITED STATES METAGENOMIC SEQUENCING MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 87. UNITED STATES METAGENOMIC SEQUENCING MARKET INVESTMENT & FUNDING
TABLE 88. UNITED STATES METAGENOMIC SEQUENCING MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 89. UNITED STATES METAGENOMIC SEQUENCING MARKET: LICENSE & PRICING

Companies Mentioned

  • Azenta US, Inc.
  • BGI Genomics Co., Ltd.
  • CosmosID
  • DNASTAR, Inc.
  • Eurofins Genomics Germany GmbH
  • Freenome Holdings, Inc.
  • IntegraGen S.A.
  • Macrogen Europe BV
  • Microsynth AG
  • Novogene Co., Ltd.
  • Oxford Nanopore Technologies PLC
  • Pacific Biosciences of California, Inc.
  • PerkinElmer Inc.
  • Psomagen, Inc.
  • QIAGEN GmbH

Methodology

Loading
LOADING...